CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Insmed Incorporated Company Snapshot
Insmed Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Insmed Incorporated with three other companies in this sector in the United States: Altimmune Inc (2018 sales of $10.33 million of which 100% was Biodefence Products), Unum Therapeutics Inc ($9.73 million of which 100% was Biopharmaceutical C), and Menlo Therapeutics Inc ($10.64 million of which 100% was operates in one segment).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Insmed Incorporated
  Stock Performance Chart for Insmed Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 23.10
(Figures in U.S. Dollars)
1 Week 0.2%   13 Weeks 21.1%  
4 Weeks 35.6%   52 Weeks 46.6%  
 
Insmed Incorporated Key Data:
  Ticker: INSM Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 9,835,000
(Year Ending Jan 2019).
Employees: 373
  Currency: U.S. Dollars Market Cap: 2,063,076,800
  Fiscal Yr Ends: December Shares Outstanding: 89,310,684
  Share Type: Common Closely Held Shares: 3,627,988
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.